相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Comparison of Bayesian-derived and first-order analytic equations for calculation of vancomycin area under the curve
Katie B. Olney et al.
PHARMACOTHERAPY (2022)
Evaluation of pharmacist time dedicated to vancomycin dosing in adult patients using a 24-hour AUC nomogram or trough monitoring approach: A time motion study
Daniel Chung et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2022)
Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta-analysis
Emily Abdelmessih et al.
PHARMACOTHERAPY (2022)
Bayesian-estimated vancomycin area under the curve using a single trough concentration vs 2 concentrations
Dan Ho et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2021)
'Cost-benefit analysis comparing trough, two-level AUC, and Bayesian AUC dosing for vancomycin': authors' reply
Brian V. Lee et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Therapeutic monitoring of vancomycin for serious -methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)
Review and Validation of Bayesian Dose-Optimizing Software and Equations for Calculation of the Vancomycin Area Under the Curve in Critically Ill Patients
R. Brigg Turner et al.
PHARMACOTHERAPY (2018)
A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity
Natalie A. Finch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling
Joseph J. Carreno et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Innovative approaches to optimizing the delivery of vancomycin in individual patients
Manjunath P. Pai et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review
Jose Antonio Lopes et al.
CLINICAL KIDNEY JOURNAL (2013)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
CLINICAL INFECTIOUS DISEASES (2009)
Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations
A. H. Thomson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
M. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
PA Moise-Broder et al.
CLINICAL PHARMACOKINETICS (2004)